Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

27.98

+1.15 (4.29%)

At close: Nov 6, 2026, 4:00 PM EST

27.51

-0.47 (-1.68%)

After-hours: Nov 6, 2026, 7:30 PM EST

Adaptive Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	298.01	276.98	178.96	170.28	185.31	154.34
Revenue Growth	17.90%	54.77%	5.10%	-8.11%	20.06%	56.88%
Cost of Revenue	160.21	165.13	175.03	197.67	199.67	191.64
Gross Profit	137.8	111.85	3.92	-27.39	-14.36	-37.3
Selling, General & Admin	184.31	167.27	157.57	172.51	184.13	169.97
Amortization of Goodwill & Intangibles	1.7	1.7	1.7	1.7	1.7	1.7
Operating Expenses	186.01	168.97	159.27	174.21	185.83	171.67
Operating Income	-48.21	-57.12	-155.34	-201.61	-200.19	-208.97
Interest Expense	-9.04	-11.78	-11.58	-13.8	-4.24	-
Interest & Investment Income	9.07	6.93	6.33	6.35	4.8	8.9
EBT Excluding Unusual Items	-48.18	-61.97	-160.6	-209.06	-199.63	-200.07
Merger & Restructuring Charges	-	-	-7.21	-	-	-
Gain (Loss) on Sale of Investments	1.18	2.51	8.21	9.18	-0.74	-7.23
Asset Writedown	-	-	-	-25.43	-	-
Pretax Income	-70.73	-59.46	-159.6	-225.3	-200.37	-207.3
Earnings From Continuing Operations	-70.73	-59.46	-159.6	-225.3	-200.37	-207.3
Minority Interest in Earnings	0.21	-0.04	0.1	0.05	0.18	0.02
Net Income	-70.52	-59.5	-159.49	-225.25	-200.19	-207.28
Net Income to Common	-70.52	-59.5	-159.49	-225.25	-200.19	-207.28
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	157	152	147	144	143	140
Shares Outstanding (Diluted)	157	152	147	144	143	140
Shares Change	4.58%	3.14%	1.88%	1.31%	1.54%	6.96%
EPS (Basic)	-0.45	-0.39	-1.08	-1.56	-1.40	-1.48
EPS (Diluted)	-0.45	-0.39	-1.08	-1.56	-1.40	-1.48
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-8.82	-48.95	-98.88	-167.02	-200.29	-254.47
Free Cash Flow Per Share	-0.06	-0.32	-0.67	-1.16	-1.41	-1.81
Gross Margin	46.24%	40.38%	2.19%	-16.09%	-7.75%	-24.17%
Operating Margin	-16.18%	-20.62%	-86.80%	-118.40%	-108.03%	-135.39%
Profit Margin	-23.66%	-21.48%	-89.12%	-132.28%	-108.03%	-134.30%
Free Cash Flow Margin	-2.96%	-17.67%	-55.25%	-98.09%	-108.09%	-164.87%
EBITDA	-32.87	-39.29	-136.09	-179.38	-179.27	-195.01
EBITDA Margin	-11.03%	-14.19%	-76.05%	-105.34%	-96.74%	-126.35%
D&A For EBITDA	15.33	17.83	19.26	22.23	20.92	13.95
EBIT	-48.21	-57.12	-155.34	-201.61	-200.19	-208.97
EBIT Margin	-16.18%	-20.62%	-86.80%	-118.40%	-108.03%	-135.39%
Advertising Expenses	-	4.1	6.1	8.6	13.7	-

SEC Filings: 10-K · 10-Q